ARTICLE | Company News
Arius, Fusion Antibodies deal
March 5, 2007 8:00 AM UTC
Fusion will use its Fusion Expression Technology (FET) high-throughput screening platform to engineer new recombinant antibodies for ARI to treat cancer. Financial terms were not disclosed. ...